Literature DB >> 22926119

[Anti-inflammatory mechanism of Lactobacillus rhamnosus GG in lipopolysaccharide- stimulated HT-29 cell].

Sang Kil Lee1, Kyung Min Yang, Jae Hee Cheon, Tae Il Kim, Won Ho Kim.   

Abstract

BACKGROUND/AIMS: Probiotics are live non-pathogenic organisms that belong to the resident microflora, and confer health benefits by multiple mechanisms. Lactobacillus rhamnosus GG (LGG) is one of the probiotic bacteria that ameliorates intestinal injury and inflammation caused by various stimuli. We aimed to evaluate the anti-inflammatory effect and mechanism of LGG in lipopolysaccharide (LPS)-stimulated HT-29 cells.
METHODS: HT-29 cells were stimulated with interleukin (IL)-1β (2 ng/mL), tumor necrosis factor (TNF)-α (20 ng/mL), and LPS (20 μg/mL) in the presence or absence of LGG (10⁷-10⁹ colony forming units/mL). Production of the pro-inflammatory chemokine IL-8 was measured by ELISA and semi-quantitative PCR. Transcriptional activity of NF-kB-responsive gene was evaluated by luciferase assay with reporter gene. Toll-like receptor 4 (TLR4) mRNA expression was assessed by semi-quantitative PCR. The IκBa degradation was evaluated by western blot and intranuclear translocation of NF-κB was determined by western blot and immunofluorescence.
RESULTS: LGG did not affect the viability of HT-29 cells. Pretreatment of HT-29 cells with LGG significantly blocked TNF-α, and LPS induced IL-8 activation at both mRNA and protein level (p<0.05). Pretreatment of HT-29 cells with LGG attenuated LPS-induced NF-κB nuclear translocation and also blocked LPS-induced IκBα degradation. LGG also down-regulated TLR4 mRNA activated by LPS.
CONCLUSIONS: LGG attenuates LPS induced inflammation, and this may be associated with TLR4/NF-κB down-regulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926119     DOI: 10.4166/kjg.2012.60.2.86

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  9 in total

Review 1.  Probiotic mediated NF-κB regulation for prospective management of type 2 diabetes.

Authors:  Rabia Bhardwaj; Brij Pal Singh; Nitika Sandhu; Niharika Singh; Ravinder Kaur; Namita Rokana; Kumar Siddharth Singh; Vishu Chaudhary; Harsh Panwar
Journal:  Mol Biol Rep       Date:  2020-01-09       Impact factor: 2.316

2.  Transcriptomic Profile of Whole Blood Cells from Elderly Subjects Fed Probiotic Bacteria Lactobacillus rhamnosus GG ATCC 53103 (LGG) in a Phase I Open Label Study.

Authors:  Gloria Solano-Aguilar; Aleksey Molokin; Christine Botelho; Anne-Maria Fiorino; Bryan Vinyard; Robert Li; Celine Chen; Joseph Urban; Harry Dawson; Irina Andreyeva; Miriam Haverkamp; Patricia L Hibberd
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

3.  Isolated exopolysaccharides from Lactobacillus rhamnosus GG alleviated adipogenesis mediated by TLR2 in mice.

Authors:  Zhen Zhang; Zhigang Zhou; Yu Li; Linkang Zhou; Qianwen Ding; Li Xu
Journal:  Sci Rep       Date:  2016-10-27       Impact factor: 4.379

4.  Treatment with the Probiotic Product Aviguard® Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice.

Authors:  Markus M Heimesaat; Dennis Weschka; Soraya Mousavi; Stefan Bereswill
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

Review 5.  Role of endogenous microbiota, probiotics and their biological products in human health.

Authors:  Gordon S Howarth; Hanru Wang
Journal:  Nutrients       Date:  2013-01-10       Impact factor: 5.717

6.  Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.

Authors:  Yvonne Ritze; Gyöngyi Bárdos; Anke Claus; Veronika Ehrmann; Ina Bergheim; Andreas Schwiertz; Stephan C Bischoff
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

Review 7.  Gut microbiota, probiotics and diabetes.

Authors:  Aline Corado Gomes; Allain Amador Bueno; Rávila Graziany Machado de Souza; João Felipe Mota
Journal:  Nutr J       Date:  2014-06-17       Impact factor: 3.271

8.  Screening and Characterization of Lactic Acid Bacteria Strains with Anti-inflammatory Activities through in vitro and Caenorhabditis elegans Model Testing.

Authors:  Hye Kyoung Lee; Sun-Hae Choi; Cho Rong Lee; Sun Hee Lee; Mi Ri Park; Younghoon Kim; Myung-Ki Lee; Geun-Bae Kim
Journal:  Korean J Food Sci Anim Resour       Date:  2015-02-28       Impact factor: 2.622

Review 9.  Limosilactobacillus reuteri in Health and Disease.

Authors:  Jumana Abuqwider; Mohammad Altamimi; Gianluigi Mauriello
Journal:  Microorganisms       Date:  2022-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.